Articles by Stephanie Sutton - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Stephanie Sutton

News

Aug 1, 2012

Pharmacovigilance rules enter into effect.

Medicines Top EU's Counterfeit List

Jul 30, 2012

A report from the European Commission shows that fake pharmaceuticals were the top articles detained by European Union customs in 2011.

EC Investigates Lundbeck for Potential Pay-to-Delay Agreements

Jul 27, 2012

The European Commission has issued a statement of objections against Lundbeck and several other pharmaceutical companies with the preliminary view that Lundbeck formed agreements with generic-drug companies to prevent the market entry of cheaper versions of its antidepressant, citalopram.

UK Consults on Early Medicines Access

Jul 23, 2012

The UK's Medicines and Healthcare products Regulatory Agency has launched a public consultation regarding a scheme that could provide patients with access to unlicensed medicines in Phase II or III clinical trials.

EC Offers Aid to Former AstraZeneca Workers

Jul 20, 2012

The European Commission is looking to provide Sweden with EUR4.3 million to help 700 workers affected by AstraZeneca job cuts to find new work.

Analytical Tools for a Quality-by-Design Approach to Lyophilization

Experts share insights into analytical tools and techniques.
Jul 18, 2012

Experts share insights into analytical tools and techniques.

GSK to Acquire Human Genome Sciences for $3.6 Billion

Jul 18, 2012

GlaxoSmithKline has announced that it will acquire Human Genome Sciences (HGS) for $14.25 per share in cash, or approximately $3.6 billion on an equity basis.

35th Anniversary Special: Reader Views on Changes in Pharmaceutical Manufacturing

Readers point to quality by design as having a significant influence on manufacturing and drug development during the past decade.
Jul 2, 2012

Readers point to quality by design as having a significant influence on manufacturing and drug development during the past decade.

Lyophilization: How to Meet Scale-Up Challenges Using QbD

Experts share how to choose analytical tools and techniques when scaling up a lyophilization process.
Jul 2, 2012

Experts share how to choose analytical tools and techniques when scaling up a lyophilization process.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here